Scientific publications are the foundation on which a drug’s identity is created, playing a crucial part in all marketing and communications efforts behind the brand. As the life sciences industry’s leading event, CBI’s Publication Planning 2017 will provide in-depth content on and analysis of current practices and emerging regulations and technologies.
CBI’s content is tailored to provide critical insights for life sciences companies, both large and small. Key topics addressed will include the new ICMJE data sharing requirements, adapting publications for global release, and the integration of new types of data, including HEOR, into publications.
The program will also cover the role of digital platforms for publication planning, as well as new opportunities to develop metrics to measure the efficacy of publications. Opportunities to improve collaboration, communication and streamlined workflows will also be examined.